Skip to main content

Advertisement

Log in

ABCC8 Single Nucleotide Polymorphisms are Associated with Cerebral Edema in Severe TBI

  • Original Article
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Objective

Cerebral edema (CE) in traumatic brain injury (TBI) is the consequence of multiple underlying mechanisms and is associated with unfavorable outcomes. Genetic variability in these pathways likely explains some of the clinical heterogeneity observed in edema development. A role for sulfonylurea receptor-1 (Sur1) in CE is supported. However, there are no prior studies examining the effect of genetic variability in the Sur1 gene (ABCC8) on the development of CE. We hypothesize that ABCC8 single nucleotide polymorphisms (SNPs) are predictive of CE.

Methods

DNA was extracted from 385 patients. SNPs in ABCC8 were genotyped using the Human Core Exome v1.2 (Illumina). CE measurements included acute CT edema, mean and peak intracranial pressure (ICP), and need for decompressive craniotomy.

Results

Fourteen SNPs with minor allele frequency >0.2 were identified. Four SNPS rs2283261, rs3819521, rs2283258, and rs1799857 were associated with CE measures. In multiple regression models, homozygote-variant genotypes in rs2283261, rs3819521, and rs2283258 had increased odds of CT edema (OR 2.45, p = 0.007; OR 2.95, p = 0.025; OR 3.00, p = 0.013), had higher mean (β = 3.13, p = 0.000; β = 2.95, p = 0.005; β = 3.20, p = 0.008), and peak ICP (β = 8.00, p = 0.001; β = 7.64, p = 0.007; β = 6.89, p = 0.034). The homozygote wild-type genotype of rs1799857 had decreased odds of decompressive craniotomy (OR 0.47, p = 0.004).

Conclusions

This is the first report assessing the impact of ABCC8 genetic variability on CE development in TBI. Minor allele ABCC8 SNP genotypes had increased risk of CE, while major SNP alleles were protective—potentially suggesting an evolutionary advantage. These findings could guide risk stratification, treatment responders, and the development of novel targeted or gene-based therapies against CE in TBI and other neurological disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Dardiotis E, Paterakis K, Tsivgoulis G, Tsintou M, Hadjigeorgiou GF, Dardioti M, et al. AQP4 tag single nucleotide polymorphisms in patients with traumatic brain injury. J Neurotrauma. 2014;31:1920–6.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Dardiotis E, Fountas KN, Dardioti M, Xiromerisiou G, Kapsalaki E, Tasiou A, et al. Genetic association studies in patients with traumatic brain injury. Neurosurg Focus. 2010;28:E9.

    Article  PubMed  Google Scholar 

  3. Narayan RK, Kishore PR, Becker DP, Ward JD, Enas GG, Greenberg RP, et al. Intracranial pressure: to monitor or not to monitor? A review of our experience with severe head injury. J Neurosurg. 1982;56:650–9.

    Article  CAS  PubMed  Google Scholar 

  4. Liang F, Luo C, Xu G, Su F, He X, Long S, et al. Deletion of aquaporin-4 is neuroprotective during the acute stage of micro traumatic brain injury in mice. Neurosci Lett. 2015;598:29–35.

    Article  CAS  PubMed  Google Scholar 

  5. Yao X, Uchida K, Papadopoulos MC, Zador Z, Manley GT, Verkman AS. Mildly reduced brain swelling and improved neurological outcome in aquaporin-4 knockout mice following controlled cortical impact brain injury. J Neurotrauma. 2015;32(19):1458–64.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Laird MD, Shields JS, Sukumari-Ramesh S, Kimbler DE, Fessler RD, Shakir B, et al. High mobility group box protein-1 promotes cerebral edema after traumatic brain injury via activation of toll-like receptor 4. Glia. 2014;62:26–38.

    Article  PubMed  Google Scholar 

  7. Simard JM, Chen M, Tarasov KV, Bhatta S, Ivanova S, Melnitchenko L, et al. Newly expressed SUR1-regulated NC (Ca-ATP) channel mediates cerebral edema after ischemic stroke. Nat Med. 2006;12:433–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Patel AD, Meriggioli MN, Sanders DB, Gerzanich V, Geng Z, Simard JM. Glibenclamide reduces hippocampal injury and preserves rapid spatial learning in a model of traumatic brain injury. J Neuropathol Exp Neurol. 2010;69:1177–90.

    Article  CAS  PubMed  Google Scholar 

  9. Simard JM, Kilbourne M, Tsymbalyuk O, Tosun C, Caridi J, Ivanova S, et al. Key role of sulfonylurea receptor 1 in progressive secondary hemorrhage after brain contusion. J Neurotrauma. 2009;26:2257–67.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Walcott BP, Kahle KT, Simard JM. Novel treatment targets for cerebral edema. Neurotherapeutics. 2011;9:65–72.

    Article  PubMed Central  Google Scholar 

  11. Huang L-Q, Zhu G-F, Deng Y-Y, Jiang W-Q, Fang M, Chen C-B, et al. Hypertonic saline alleviates cerebral edema by inhibiting microglia-derived TNF-α and IL-1β-induced Na–K–Cl Cotransporter up-regulation. J Neuroinflamm. 2014;11:102.

    Article  Google Scholar 

  12. Marmarou CR, Liang X, Abidi NH, Parveen S, Taya K, Henderson SC, et al. Selective vasopressin-1a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and GFAP, V1aR and AQP4 expression after focal traumatic brain injury. Brain Res. 2014;1581:89–102.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Chen J-H, Yang L-K, Chen L, Wang Y-H, Wu Y, Jiang B-J, et al. Atorvastatin ameliorates early brain injury after subarachnoid hemorrhage via inhibition of AQP4 expression in rabbits. Int J Mol Med. 2016;37:1059–66.

    CAS  PubMed  Google Scholar 

  14. Cousar JL, Conley YP, Willyerd FA, Sarnaik AA, Puccio AM, Empey PE, et al. Influence of ATP-binding cassette polymorphisms on neurological outcome after traumatic brain injury. Neurocrit Care. 2013;19:192–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Simard JM, Woo SK, Schwartzbauer GT, Gerzanich V. Sulfonylurea receptor 1 in central nervous system injury: a focused review. J Cereb Blood Flow Metab. 2012;32:1699–717.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Remedy Pharmaceuticals, Inc. A phase I randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and pharmacokinetics of escalating doses of RP-1127 (glyburide for injection) in healthy male and female volunteers. 2016. p. 1–3. https://clinicaltrials.gov/ct2/show/NCT01132703?term=glibenclamide+traumatic+brain+injury&rank=2.

  17. Sheth KN, Elm JJ, Beslow LA, Sze GK, Kimberly WT. Glyburide advantage in malignant edema and stroke (GAMES-RP) trial: rationale and design. Neurocrit Care. 2016;24:132–9.

    Article  CAS  PubMed  Google Scholar 

  18. Kimberly WT, Battey TWK, Pham L, Wu O, Yoo AJ, Furie KL, et al. Glyburide is associated with attenuated vasogenic edema in stroke patients. Neurocrit Care. 2014;20(2):193–201.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature. 2001;409:928–33.

    Article  CAS  PubMed  Google Scholar 

  20. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Conley YP, Okonkwo DO, Deslouches S, Alexander S, Puccio AM, Beers SR, et al. Mitochondrial polymorphisms impact outcomes after severe traumatic brain injury. J Neurotrauma. 2014;31:34–41.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Carter KW, McCaskie PA, Palmer LJ. JLIN: a java based linkage disequilibrium plotter. BMC Bioinform. 2006;7:60.

    Article  Google Scholar 

  23. Eisenberg HM, Gary HE, Aldrich EF, Saydjari C, Turner B, Foulkes MA, et al. Initial CT findings in 753 patients with severe head injury. A report from the NIH Traumatic Coma Data Bank. J Neurosurg. 1990;73:688–98.

    Article  CAS  PubMed  Google Scholar 

  24. Miller MT, Pasquale M, Kurek S, White J, Martin P, Bannon K, et al. Initial head computed tomographic scan characteristics have a linear relationship with initial intracranial pressure after trauma. J Trauma Acute Care Surg. 2004;56:967–73.

    Article  Google Scholar 

  25. Dardiotis E, Jagiella J, Xiromerisiou G, Dardioti M, Vogiatzi C, Urbanik A, et al. Angiotensin-converting enzyme tag single nucleotide polymorphisms in patients with intracerebral hemorrhage. Pharmacogenet Genom. 2011;21:136–41.

    Article  CAS  Google Scholar 

  26. Balding DJ. A tutorial on statistical methods for population association studies. Nat Rev Genet. 2006;7:781–91.

    Article  CAS  PubMed  Google Scholar 

  27. Narum SR. Beyond Bonferroni: less conservative analyses for conservation genetics. Conserv Genet. 2006;7:783–7.

    Article  CAS  Google Scholar 

  28. Martínez-Valverde T, Vidal-Jorge M, Martinez-Saez E, Castro L, Arikan F, Cordero E, et al. Sulfonylurea receptor 1 in humans with post-traumatic brain contusions. J Neurotrauma. 2015;32:1478–87.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Jha R, Puccio A, Chou S, Chang C-C, Wallisch J, Molyneaux B, et al. Sulfonylurea receptor-1 as a novel biomarker for cerebral edema in patients with severe traumatic brain injury (S46.001). Neurology. 2016;86(S46):001.

    Google Scholar 

  30. Flanagan SE, Clauin S, Bellanné-Chantelot C, de Lonlay P, Harries LW, Gloyn AL, et al. Update of mutations in the genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism. Hum Mutat. 2008;30:170–80.

    Article  Google Scholar 

  31. Proverbio MC, Mangano E, Gessi A, Bordoni R, Spinelli R, Asselta R, et al. Whole genome SNP genotyping and exome sequencing reveal novel genetic variants and putative causative genes in congenital hyperinsulinism. PLoS ONE. 2013;8(7):e68740.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Aittoniemi J, Fotinou C, Craig TJ, de Wet H, Proks P, Ashcroft FM. SUR1: a unique ATP-binding cassette protein that functions as an ion channel regulator. Philos Trans R Soc B Biol Sci. 2009;364:257–67.

    Article  CAS  Google Scholar 

  33. Denton JS, Jacobson DA. Channeling dysglycemia: ion-channel variations perturbing glucose homeostasis. Trends Endocrinol Metab. 2012;23:41–8.

    Article  CAS  PubMed  Google Scholar 

  34. Aguilar-Bryan L, Bryan J. Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr Rev. 1999;20:101–35.

    CAS  PubMed  Google Scholar 

  35. Hardy OT, Hernandez-Pampaloni M, Saffer JR, Suchi M, Ruchelli E, Zhuang H, et al. Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan. J Pediatr. 2007;150:140–5.

    Article  CAS  PubMed  Google Scholar 

  36. Nestorowicz A, Glaser B, Wilson BA, Shyng S-L, Nichols CG, Stanley CA, et al. Genetic heterogeneity in familial hyperinsulinism. Hum Mol Genet. 1998;7:1119–28.

    Article  CAS  PubMed  Google Scholar 

  37. Glaser B, Ryan F, Donath M, Landau H, Stanley CA. Hyperinsulinism caused by paternal-specific inheritance of a recessive mutation in the sulfonylurea-receptor gene. Diabetes. 1999;48:1652–7.

    Article  CAS  PubMed  Google Scholar 

  38. Stanley CA, Thornton PS, Ganguly A, MacMullen C, Underwood P, Bhatia P, et al. Preoperative evaluation of infants with focal or diffuse congenital hyperinsulinism by intravenous acute insulin response tests and selective pancreatic arterial calcium stimulation. J Clin Endocrinol Metab. 2004;89:288–96.

    Article  CAS  PubMed  Google Scholar 

  39. Knight JC. Functional implications of genetic variation in non-coding DNA for disease susceptibility and gene regulation. Clin Sci. 2003;104:493–501.

    Article  CAS  PubMed  Google Scholar 

  40. Ritter AC, Kammerer CM, Brooks MM, Conley YP, Wagner AK. Genetic variation in neuronal glutamate transport genes and associations with posttraumatic seizure. Epilepsia. 2016;57:984–93.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

We are grateful to NIH Grant Nos. KL2 TR000146 (RMJ), R00 NR013176 (YPC), R01 NR013342 (YPC) and T32 HD040686 (JW) for their generous support.

Author Contributions

Ruchira M. Jha was involved in study concept, design, data analysis and interpretation, and manuscript generation. Ava M. Puccio, David O. Okonkwo, and Benjamin E. Zusman were involved in acquisition of data. Seo-Young Park was involved in statistical analysis review. Jessica Wallisch, Philip E. Empey, Lori A. Shutter, and Robert S. B. Clark were involved in content expertise and critical revision of the manuscript. Patrick M. Kochanek was involved in study concept, content expertise, and critical revision of manuscript. Yvette P. Conley was involved in study concept, data acquisition and interpretation, supervision, and critical revision of manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ruchira M. Jha.

Ethics declarations

Conflict of interest

Ruchira M. Jha, Ava M. Puccio, David O. Okonkwo, Benjamin E. Zusman, Seo-Young Park, Jessica Wallisch, and Philip E. Empey report no disclosures. Lori A. Shutter reports DOD Grant W81XWH-08-2-0159 and NINDS Grant 1U10NS069498. This funding was not related to this study, and there are no conflicts of interest. Robert S. B. Clark reports no disclosures. Patrick M. Kochanek has grants from NIH and the U.S. DoD. He is editor-in-chief of the journal Pediatric Critical Care Medicine and receives an editor stipend. He is one of the editors of the Textbook of Critical Care and receives royalties for that work. He is a co-author of several US patents or provisional patents (below): United States Patent: US 8,628,512 B2 Title Method of Inducing EPR Following Cardiopulmonary Arrest. Filing Date 6/22/05. Inventors PM Kochanek, SA Tisherman, X Wu, SW Stezoski, LJ Yaffe. United States Provisional Patent Title Compositions and Methods for Identifying Subjects at Risk for Traumatic Brain Injury. Serial No 62/113,292. Filing Date February 6, 2015. Inventors RP Berger, PM Kochanek, BJ Pak, PT Smith, MD Kolesnikova. United States Invention Disclosure Title Small Molecule Inhibitors of RNA Binding MOTIF (RBM) Proteins for the Treatment of Acute Cellular Injury. University of Pittsburgh. Filing Date November 13, 2014. Inventors TC Jackson, J Verrier, PM Kochanek. United States Invention Disclosure Title Method to improve neurologic outcomes in temperature managed patients. Application No. 62/164,205. Country United States. Innovators Travis C. Jackson (University of Pittsburgh); Patrick M. Kochanek. Yvette P. Conley reports no disclosures.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jha, R.M., Puccio, A.M., Okonkwo, D.O. et al. ABCC8 Single Nucleotide Polymorphisms are Associated with Cerebral Edema in Severe TBI. Neurocrit Care 26, 213–224 (2017). https://doi.org/10.1007/s12028-016-0309-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-016-0309-z

Keywords

Navigation